Product Program year 2019 Source: CMS Open Payments

Varithena

Drug Foam Sclerotherapy

NDC 60635-118-01

Open in the dashboard

General payments

$437,755

2,057 payments

Research payments

$76,244

57 payments

Through program year 2019, $437,755 in general payments and $76,244 in research payments were reported against Varithena (Foam Sclerotherapy).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $437,755 2,057
2019 Research $76,244 57

Breakdown

Who paid General payments · program year 2019
  1. Biocompatibles, Inc. $425,921 2,022 payments
  2. Biocompatibles UK Ltd $10,000 1 payment
  3. BTG International, Inc. $1,434 29 payments
  4. EKOS Corporation $400 5 payments
Top recipients General payments · program year 2019
  1. Steven Elias Vascular Surgery · Englewood, NJ $106,636 24% · 5 payments
  2. Amjad Alkadri Vascular & Interventional Radiology · Valparaiso, IN $50,819 12% · 25 payments
  3. Michael Shao Vascular Surgery · Fort Wayne, IN $47,039 11% · 13 payments
  4. Antonios Gasparis Vascular Surgery · Huntington, NY $29,353 7% · 9 payments
  5. Vinay Satwah Interventional Cardiology · Greenbelt, MD $25,413 6% · 29 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Vascular Surgery Surgery $260,375 60% · 300 practitioners
  2. Vascular & Interventional Radiology Radiology $56,043 13% · 88 practitioners
  3. Interventional Cardiology Internal Medicine $30,327 7% · 89 practitioners
  4. Diagnostic Radiology Radiology $23,600 5% · 45 practitioners
  5. Transplant Surgery $15,979 4% · 1 practitioner

The top 5 of 68 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. New Jersey $116,983 27% · 55 recipients
  2. Indiana $52,156 12% · 20 recipients
  3. Illinois $49,749 11% · 56 recipients
  4. New York $32,989 8% · 60 recipients
  5. Maryland $26,792 6% · 24 recipients

The top 5 of 47 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

2,057 general · 57 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record